Two classes of compounds have captured significant attention in biomedical research over the past two decades: SARMs and peptides. While they are often discussed in the same breath, particularly in the context of muscle biology and performance science, they are fundamentally different in structure, origin, and mechanism. Understanding what each is used for in research helps clarify why both continue to attract serious scientific interest.
What Are SARMs?
SARMs, or Selective Androgen Receptor Modulators, are synthetic compounds designed to bind to androgen receptors in a tissue-selective manner. Unlike anabolic steroids, which activate androgen receptors throughout the entire body, SARMs are engineered to preferentially target muscle and bone tissue while minimising activity elsewhere. They were originally developed as potential treatments for conditions involving muscle wasting, osteoporosis, and hypogonadism. Commonly researched SARMs include Ostarine (Enobosarm), Ligandrol (LGD-4033), and RAD-140. As of 2025, no SARM has received FDA approval, though several remain in clinical trials.
What Are Peptides?
Peptides are short chains of amino acids, typically between 2 and 50 amino acids in length, that act as signalling molecules throughout the body. Many peptides occur naturally in humans, regulating everything from hormonal signalling and immune function to tissue repair and metabolism. Synthetic research peptides are designed to replicate or enhance specific biological functions. Commonly studied examples include BPC-157, TB-500, CJC-1295, Ipamorelin, Sermorelin, and HGH Fragment 176-191. Because peptides interact with so many different biological systems, their research scope is considerably broader than that of SARMs.
SARMs in Muscle and Bone Research
The primary focus of SARM research has been their potential anabolic effects on muscle and bone tissue. Studies have explored their application in conditions such as cancer cachexia, age-related sarcopenia, and osteoporosis, where maintaining or rebuilding muscle and bone mass is clinically significant. Research into compounds like Ligandrol and RAD-140 has documented lean mass gains in controlled settings, though the challenge of achieving true tissue selectivity remains an ongoing area of scientific debate. The hormonal suppression observed in some SARM studies, particularly effects on the hypothalamic-pituitary-gonadal axis, continues to be a key research concern.
Peptides in Muscle Growth and Recovery Research
Research into sarms peptides and their respective roles in muscle physiology has highlighted some important distinctions in how each class of compound approaches tissue growth and recovery. Growth hormone-releasing peptides such as CJC-1295 and Ipamorelin have been studied for their ability to stimulate natural growth hormone secretion from the pituitary gland, which in turn supports muscle development and recovery. Unlike SARMs, which act directly on androgen receptors, these peptides work by amplifying the body’s own hormonal signalling pathways. BPC-157, a 15-amino acid synthetic peptide, has attracted research interest for its regenerative properties in muscle, tendon, and connective tissue. Studies in animal models have reported accelerated healing of muscle tears and tendon injuries. TB-500, another peptide studied for recovery, has shown potential in tissue remodelling and repair research.
Peptides in Fat Loss and Metabolic Research
Several peptides have been investigated specifically for their metabolic and fat loss applications. HGH Fragment 176-191, a truncated portion of the growth hormone molecule, has been studied for its selective effect on fat metabolism without the broader effects of full growth hormone. Tesamorelin, a growth hormone-releasing hormone analogue, is one of the few peptides with FDA approval, specifically for HIV-associated lipodystrophy, and continues to be studied more broadly for metabolic applications. Research in this area generally focuses on how growth hormone-related peptides influence body composition by promoting lipolysis and supporting lean mass retention.
Peptides in Healing and Anti-Aging Research
Beyond muscle and metabolism, peptides are studied for a wide range of regenerative and anti-aging applications. BPC-157 has attracted interest for gut healing, neurological recovery, and wound repair in preclinical research. Growth hormone peptides are studied in the context of age-related hormonal decline, where supporting natural GH output is hypothesised to slow some aspects of physiological ageing. Collagen peptides are researched for their structural role in skin and connective tissue repair. This breadth of application is one of the reasons peptide research is considered a particularly rich and expanding field.
Safety Research and Regulatory Considerations
Research has raised significant concerns about the safety profile of SARMs. The FDA has issued warnings noting associations with liver toxicity, cardiovascular risks, and hormonal suppression. A further complication is product integrity: studies have found that many products marketed as SARMs contain different substances, incorrect doses, or unapproved compounds. Peptides generally show a more favourable safety profile in research settings, though they are not without risks and require careful handling. In Australia, peptides are classified as Schedule 4 substances requiring a prescription, while SARMs are considered controlled drugs. Both are legally available only for research purposes through verified suppliers.
Final Thoughts
SARMs and peptides occupy distinct but sometimes overlapping territories in biomedical research. SARMs are primarily studied for their selective anabolic effects on muscle and bone, while peptides offer a broader research landscape spanning muscle recovery, fat metabolism, tissue healing, and anti-aging science. As research in both areas continues to develop, the scientific community’s understanding of their mechanisms, benefits, and risks will continue to evolve.
Stay in touch to get more updates & news on Economic Weekly News!
About the Author
